From July 1, 2020 to September 30, 2020, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 69,714 shares, representing 0.11% for KRW 918.87 million under the buyback announced on March 13, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,345 KRW | -4.09% |
|
-7.50% | -24.11% |
May. 20 | HLB bioStep Co.,Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. | CI |
May. 20 | HLB bioStep Co.,Ltd. authorizes a Buyback Plan. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.11% | 150M | |
-40.84% | 7.63B | |
+8.43% | 3.61B | |
-0.12% | 2.36B | |
-24.56% | 1.86B | |
-18.18% | 1.74B | |
+5.57% | 913M | |
+16.33% | 763M | |
-10.48% | 678M | |
-0.60% | 290M |
- Stock Market
- Equities
- A278650 Stock
- News HLB bioStep Co.,Ltd.
- Tranche Update on KNOTUS Co.,Ltd's Equity Buyback Plan announced on March 13, 2020.